Three-Month Outcome of Ziv-Aflibercept for Diabetic Macular Edema

  • Ameen Marashi
  • Published 2016


Diabetic macular edema (DME) is a primary cause of early onset of visual acuity reduction in patients diagnosed with diabetes mellitus and in term it will lead to a reduction in vision related quality of life in a working age group [1]. One of the main pathological factors of DME is up regulation of VEGF (Vascular endothelial growth factor) which in turn… (More)


5 Figures and Tables